Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial

  1. Manoj M Lalu
  2. Katrina J Sullivan
  3. Shirley HJ Mei
  4. David Moher
  5. Alexander Straus
  6. Dean A Fergusson
  7. Duncan J Stewart
  8. Mazen Jazi
  9. Malcolm MacLeod
  10. Brent Winston
  11. John Marshall
  12. Brian Hutton
  13. Keith R Walley
  14. Lauralyn McIntyre  Is a corresponding author
  15. on behalf of the Canadian Critical Care Translational Biology Group
  1. The Ottawa Hospital, Canada
  2. The Ottawa Hospital Research Institute, Canada
  3. The University of Edinburgh, United Kingdom
  4. University of Calgary, Canada
  5. St. Michaels Hospital, The University of Toronto, Canada
  6. University of Ottawa, Canada
1 additional file

Additional files

All additional files

Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.

https://cdn.elifesciences.org/articles/17850/elife-17850-supp-v1.zip

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Manoj M Lalu
  2. Katrina J Sullivan
  3. Shirley HJ Mei
  4. David Moher
  5. Alexander Straus
  6. Dean A Fergusson
  7. Duncan J Stewart
  8. Mazen Jazi
  9. Malcolm MacLeod
  10. Brent Winston
  11. John Marshall
  12. Brian Hutton
  13. Keith R Walley
  14. Lauralyn McIntyre
  15. on behalf of the Canadian Critical Care Translational Biology Group
(2016)
Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
eLife 5:e17850.
https://doi.org/10.7554/eLife.17850